ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,691Medicare Part D Prescriptions Filled, Including Refills

Rank: 281 out of 1206

$709K Total Retail Price of All Prescriptions

Rank: 43 out of 1206

389 Patients Receiving at Least One Drug in Part D
43%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 389 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 389 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 3,713 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$82 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LISINOPRIL 334 170 1 4
OMEPRAZOLE 311 131 2 3
LEVOTHYROXINE SODIUM 300 155 3 2
FUROSEMIDE 270 175 4 5
SIMVASTATIN 254 95 5 1
HYDROCODONE-ACETAMINOPHEN 224 70 S3 6 7
GABAPENTIN 203 83 7 18
METFORMIN HCL 190 84 8 10
TRAMADOL HCL 183 89 9 17
AMLODIPINE BESYLATE 175 104 10 6
PRAVASTATIN SODIUM 164 51 11 21
METOPROLOL SUCCINATE 162 111 12 15
TRAZODONE HCL 131 44 13 37
GLIMEPIRIDE 122 62 14 34
ATORVASTATIN CALCIUM 118 59 15 13
POTASSIUM CHLORIDE 107 70 16 12
CITALOPRAM HBR 105 49 17 16
CYMBALTA 101 53 18 63
ALENDRONATE SODIUM 100 80 19 19
WARFARIN SODIUM 92 45 20 8
NOVOLOG 89 22 21 100
RANITIDINE HCL 89 58 21 23
HYDROCHLOROTHIAZIDE 86 41 23 11
CRESTOR 86 57 23 30
SPIRIVA 82 56 25 66
CARVEDILOL 79 33 26 32
ADVAIR DISKUS 79 29 26 55
ISOSORBIDE MONONITRATE ER 76 32 28 40
CYCLOBENZAPRINE HCL 71 0 R 29 80
LOSARTAN POTASSIUM 70 46 30 20
LYRICA 68 23 31 115
ROPINIROLE HCL 64 25 32 77
ZOLPIDEM TARTRATE 61 12 33 25
METOPROLOL TARTRATE 60 30 34 9
TRUVADA 59 12 35 315
IBUPROFEN 58 16 36 116
TAMSULOSIN HCL 57 39 37 26
AMITRIPTYLINE HCL 56 23 R 38 59
LEVEMIR FLEXPEN 55 34 39 217
PAROXETINE HCL 54 13 40 53
NOVOLOG FLEXPEN 53 25 41 179
LIPITOR 52 37 42 113
BUPROPION XL 52 0 42 151
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 17, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.